Clinical Presentation, Natural History, and Prognosis of Diffuse Low-Grade Gliomas-Reference-Cited by-同舟云学术

Clinical Presentation, Natural History, and Prognosis of Diffuse Low-Grade Gliomas

Published:2019-01 Issue:1 Volume:30 Page:35-42
ISSN:1042-3680
Container-title:Neurosurgery Clinics of North America
language:en
Short-container-title:Neurosurgery Clinics of North America

Author:

Smits Anja,Jakola Asgeir S.

Publisher

Elsevier BV

Subject

Neurology (clinical),General Medicine,Surgery

Reference56 articles.

1. The 2016 World Health Organization classification of tumors of the central nervous system: a summary;Louis;Acta Neuropathol,2016

2. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas;Brat;N Engl J Med,2015

3. Diffuse low-grade oligodendrogliomas extend beyond MRI-defined abnormalities;Pallud;Neurology,2010

4. Extension of diffuse low-grade gliomas beyond radiological borders as shown by the coregistration of histopathological and magnetic resonance imaging data;Zetterling;J Neurosurg,2016

5. How often are nonenhancing supratentorial gliomas malignant? A population study;Scott;Neurology,2002

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revealing the role of SPP1+ macrophages in glioma prognosis and therapeutic targeting by investigating tumor-associated macrophage landscape in grade 2 and 3 gliomas;Cell & Bioscience;2024-03-21

2. Qualitative and Visual Along-Tract Analysis of Diffusion-Based Parameters in Patients with Diffuse Gliomas;Brain Sciences;2024-02-26

3. Diffuse low-grade glioma: What is the optimal linear measure to assess tumor growth?;Neuro-Oncology Advances;2024-01-01

4. Epidemiology and Presentation of CNS Tumors;Surgical Neuro-Oncology;2024

5. Unraveling the signaling mechanism behind astrocytoma and possible therapeutics strategies: A comprehensive review;Cancer Reports;2023-09-07